Generate:Biomedicines’ Post

View organization page for Generate:Biomedicines, graphic

30,156 followers

What does it take to build an AI-driven biotech in 2024? Our CEO Michael Nally will share his insight into this very topic as part of a panel discussion at Decoding Bio’s second annual AI x Bio Summit at the NYSE on July 25.    Convening industry leaders working at the intersection of computation and life sciences, this panel will explore company building strategies, emerging technologies, stakeholder engagement, and more.     Mike will be joined by panelists Nabiha Saklayen of Cellino and Sajith Wickramasekara of Benchling, with Bigyan Bista of Enveda Biosciences moderating the discussion.    #GenerativeAI | #UnapologeticallyScientific

  • No alternative text description for this image
Amee Kapadia

Investor @ Cantos Ventures

2mo

So excited for this discussion!

To view or add a comment, sign in

Explore topics